Acorda Therapeutics (ACOR) Tops Q3 EPS by 13c
Tweet
Share
E-mail
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Net loss per share-diluted (earnings per share): -0.28
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss per share-diluted (earnings per share): -0.28
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q3 EPS of ($1.43), $0.13 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $31.45 million versus the consensus estimate of $30.57 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
